Myeloma Investment Fund Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma
May 16, 2023
View
Answers to FAQs from our 5/5/23 webinar on Clinical Studies
May 15, 2023
Answers to FAQs from our 4/5/23 webinar on Multiple Myeloma Precursor Conditions
April 14, 2023
Answers to FAQs from our 3/21/23 webinar on BCMA-Targeted Bispecific Antibodies
March 27, 2023
Meet Sid Moss, MMRF 2023 Walk/Run: Southeast Michigan Spirit of Hope Honoree
March 16, 2023
Meet Lester Weinraub, MMRF 2023 Walk/Run: Philadelphia Spirit of Hope Honoree
March 14, 2023
Meet Walk/Run Team “Tim’s Street Rodders” who participate in memory of Tim Poll, MMRF 2023 Walk/Run: Scottsdale Spirit of Hope Honoree
March 8, 2023
Answers to FAQs from our 2/17/23 webinar on Newly Diagnosed Multiple Myeloma
February 27, 2023
The MMRF and Lazarex Cancer Foundation Partner to Improve Equitable Access to Myeloma Clinical Trials
Meet Will Sanchez, MMRF 2023 Walk/Run: New York City Spirit of Hope Honoree
February 13, 2023
Meet Erik Ellefsen, MMRF 2023 Walk/Run: San Francisco Spirit of Hope Honoree
February 10, 2023
The MMRF CureCloud® Multiple Myeloma Research Study
February 2, 2023
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
Get Your Free Toolkit